Patient characteristics from a medical cannabis provider
暂无分享,去创建一个
Liying Zhang | H. Lam | E. Chow | C. DeAngelis | B. A. Wan | Stephanie Chan | Alexia Blake | M. Slaven | V. Ganesh | S. O’Hearn | L. Malek | A. Wolt | Pearl Zaki | E. Shaw
[1] Xia Zhang,et al. Endocannabinoid system: Role in depression, reward and pain control (Review) , 2016, Molecular medicine reports.
[2] Matthew D. DiDonato,et al. Medical Cannabis in Arizona: Patient Characteristics, Perceptions, and Impressions of Medical Cannabis Legalization , 2015, Journal of psychoactive drugs.
[3] Alan J. Thompson,et al. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity , 2014, Neurology.
[4] Robert Kay,et al. Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use. , 2013, The International journal on drug policy.
[5] C. Reinarman,et al. Who Are Medical Marijuana Patients? Population Characteristics from Nine California Assessment Clinics , 2011, Journal of psychoactive drugs.
[6] George A Fraser,et al. The Use of a Synthetic Cannabinoid in the Management of Treatment‐Resistant Nightmares in Posttraumatic Stress Disorder (PTSD) , 2009, CNS neuroscience & therapeutics.
[7] Timothy S. Carey,et al. Accuracy of the Pain Numeric Rating Scale as a Screening Test in Primary Care , 2007, Journal of General Internal Medicine.
[8] J. Manzanares,et al. Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes. , 2006, Current neuropharmacology.
[9] M. Amar. Cannabinoids in medicine: A review of their therapeutic potential. , 2006 .
[10] M. Elsohly,et al. Chemical constituents of marijuana: the complex mixture of natural cannabinoids. , 2005, Life sciences.
[11] F. Grotenhermen. The Cannabinoid System-A Brief Review , 2004 .
[12] R. Birch,et al. Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial , 2004, Pain.
[13] H. Adams,et al. The medicinal use of cannabis in the UK: results of a nationwide survey , 2004, International journal of clinical practice.
[14] F. Grotenhermen. Clinical Pharmacodynamics of Cannabinoids , 2004 .
[15] C. Burckhardt,et al. The Quality of Life Scale (QOLS): Reliability, Validity, and Utilization , 2003, Health and quality of life outcomes.
[16] J. Farrar,et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale , 2001, PAIN.
[17] D. Spiegelhalter,et al. Quality of life measures in health care. II: Design, analysis, and interpretation. , 1992, BMJ.
[18] A. Hazekamp,et al. Review on clinical studies with cannabis and cannabinoids 2005-2009 , 2010 .